Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Jacobs Solutions Inc. stock logo
J
Jacobs Solutions
$143.11
+0.7%
$130.53
$106.23
$150.54
$17.20B0.77823,342 shs129,642 shs
PayPal Holdings, Inc. stock logo
PYPL
PayPal
$78.48
+0.8%
$73.08
$55.85
$93.66
$76.37B1.4510.86 million shs3.54 million shs
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$566.32
+0.3%
$543.18
$476.49
$1,211.20
$61.12B0.331.12 million shs349,007 shs
UBS Group AG stock logo
UBS
UBS Group
$38.38
+0.4%
$33.52
$25.75
$38.41
$122.98B1.153.25 million shs1.01 million shs
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Jacobs Solutions Inc. stock logo
J
Jacobs Solutions
+0.27%+1.95%+9.63%+16.80%-0.57%
PayPal Holdings, Inc. stock logo
PYPL
PayPal
+1.51%+5.36%+5.76%+19.10%+34.01%
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
-1.35%+2.66%+8.11%-6.31%-46.78%
UBS Group AG stock logo
UBS
UBS Group
+0.24%+5.96%+19.09%+27.15%+27.32%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Jacobs Solutions Inc. stock logo
J
Jacobs Solutions
2.2869 of 5 stars
1.33.01.70.03.03.31.3
PayPal Holdings, Inc. stock logo
PYPL
PayPal
4.4557 of 5 stars
2.24.00.03.23.32.52.5
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
4.8223 of 5 stars
4.43.01.72.32.81.71.9
UBS Group AG stock logo
UBS
UBS Group
3.7549 of 5 stars
0.04.01.70.03.00.03.8
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Jacobs Solutions Inc. stock logo
J
Jacobs Solutions
2.67
Moderate Buy$151.385.78% Upside
PayPal Holdings, Inc. stock logo
PYPL
PayPal
2.46
Hold$83.135.93% Upside
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
2.75
Moderate Buy$828.8646.36% Upside
UBS Group AG stock logo
UBS
UBS Group
2.55
Moderate BuyN/AN/A

Current Analyst Ratings Breakdown

Latest PYPL, J, REGN, and UBS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/23/2025
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$850.00
7/22/2025
UBS Group AG stock logo
UBS
UBS Group
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderperform ➝ Neutral
7/18/2025
PayPal Holdings, Inc. stock logo
PYPL
PayPal
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$80.00 ➝ $90.00
7/17/2025
PayPal Holdings, Inc. stock logo
PYPL
PayPal
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageHold$75.00
7/16/2025
Jacobs Solutions Inc. stock logo
J
Jacobs Solutions
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSector Weight ➝ Overweight$155.00
7/14/2025
PayPal Holdings, Inc. stock logo
PYPL
PayPal
Seaport Res Ptn
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong Sell ➝ Hold
7/11/2025
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$560.00 ➝ $584.00
7/10/2025
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$755.00 ➝ $754.00
6/30/2025
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold
6/26/2025
PayPal Holdings, Inc. stock logo
PYPL
PayPal
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$88.00
6/24/2025
PayPal Holdings, Inc. stock logo
PYPL
PayPal
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral$74.00
(Data available from 7/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Jacobs Solutions Inc. stock logo
J
Jacobs Solutions
$11.50B1.50$7.92 per share18.08$36.76 per share3.89
PayPal Holdings, Inc. stock logo
PYPL
PayPal
$31.89B2.39$5.72 per share13.71$20.64 per share3.80
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$14.20B4.31$45.23 per share12.52$268.50 per share2.11
UBS Group AG stock logo
UBS
UBS Group
$84.56B1.46$2.79 per share13.76$26.69 per share1.44
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Jacobs Solutions Inc. stock logo
J
Jacobs Solutions
$821.09M$3.6339.4220.862.003.53%15.67%6.11%8/5/2025 (Estimated)
PayPal Holdings, Inc. stock logo
PYPL
PayPal
$4.15B$4.4717.5713.941.2614.26%24.59%6.06%7/29/2025 (Estimated)
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$4.41B$39.2814.4114.902.1431.94%15.27%11.93%8/1/2025 (Estimated)
UBS Group AG stock logo
UBS
UBS Group
$5.09B$1.5125.4012.710.687.13%5.82%0.32%7/30/2025 (Estimated)

Latest PYPL, J, REGN, and UBS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/5/2025Q3 2025
Jacobs Solutions Inc. stock logo
J
Jacobs Solutions
$1.56N/AN/AN/A$3.09 billionN/A
8/1/2025Q2 2025
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$8.53N/AN/AN/A$3.30 billionN/A
7/30/2025Q2 2025
UBS Group AG stock logo
UBS
UBS Group
$0.52N/AN/AN/A$9.77 billionN/A
7/29/2025Q2 2025
PayPal Holdings, Inc. stock logo
PYPL
PayPal
$1.29N/AN/AN/A$8.08 billionN/A
5/6/2025Q2 2025
Jacobs Solutions Inc. stock logo
J
Jacobs Solutions
$1.41$1.43+$0.02$0.05$3.00 billion$2.91 billion
4/30/2025Q1 2025 (Fixed Income)
UBS Group AG stock logo
UBS
UBS Group
$0.42$0.51+$0.09$0.51$10.19 billion$11.90 billion
4/29/2025Q1 2025
PayPal Holdings, Inc. stock logo
PYPL
PayPal
$1.16$1.33+$0.17$1.29$7.84 billion$7.79 billion
4/29/2025Q1 2025
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$8.83$8.22-$0.61$7.27$3.40 billion$3.03 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Jacobs Solutions Inc. stock logo
J
Jacobs Solutions
$1.280.89%N/A35.26%4 Years
PayPal Holdings, Inc. stock logo
PYPL
PayPal
N/AN/AN/AN/AN/A
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$3.520.62%N/A8.96%N/A
UBS Group AG stock logo
UBS
UBS Group
N/AN/AN/AN/A5 Years

Latest PYPL, J, REGN, and UBS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/30/2025
Jacobs Solutions Inc. stock logo
J
Jacobs Solutions
quarterly$0.321.03%5/23/20255/23/20256/20/2025
5/20/2025
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
quarterly$0.880.6%5/20/20255/20/20256/6/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Jacobs Solutions Inc. stock logo
J
Jacobs Solutions
0.68
1.50
1.50
PayPal Holdings, Inc. stock logo
PYPL
PayPal
0.56
1.30
1.30
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
0.09
4.93
4.03
UBS Group AG stock logo
UBS
UBS Group
3.72
1.04
1.04

Institutional Ownership

CompanyInstitutional Ownership
Jacobs Solutions Inc. stock logo
J
Jacobs Solutions
85.65%
PayPal Holdings, Inc. stock logo
PYPL
PayPal
68.32%
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
83.31%
UBS Group AG stock logo
UBS
UBS Group
N/A

Insider Ownership

CompanyInsider Ownership
Jacobs Solutions Inc. stock logo
J
Jacobs Solutions
0.38%
PayPal Holdings, Inc. stock logo
PYPL
PayPal
0.08%
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
7.02%
UBS Group AG stock logo
UBS
UBS Group
1.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Jacobs Solutions Inc. stock logo
J
Jacobs Solutions
45,000120.16 million119.70 millionOptionable
PayPal Holdings, Inc. stock logo
PYPL
PayPal
24,400972.53 million971.76 millionOptionable
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
15,106107.96 million100.39 millionOptionable
UBS Group AG stock logo
UBS
UBS Group
108,6483.21 billion3.17 billionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Jacobs Solutions stock logo

Jacobs Solutions NYSE:J

$143.10 +0.98 (+0.69%)
As of 02:49 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Jacobs Solutions Inc. provides consulting, technical, engineering, scientific, and project delivery services for the government and private sectors in the United States, Europe, Canada, India, Asia, Australia, New Zealand, the Middle East, and Africa. It operates through Critical Mission Solutions, People & Places Solutions, Divergent Solutions, and PA Consulting segments. The company offers cyber, data analytics, systems and software application integration and consulting, enterprise level and mission IT, design, nuclear, and enterprise level operations and maintenance services; software development, testing, mission integration, program management, research, development, test, evaluation services, training, and environmental remediation services; and other technical consulting solutions, as well as construction and construction management services. It also provides consulting services for consumer and manufacturing, defense and security, energy and utilities, financial services, government, health and life sciences, and transport industries. The company was founded in 1947 and is headquartered in Dallas, Texas.

PayPal stock logo

PayPal NASDAQ:PYPL

$78.48 +0.66 (+0.84%)
As of 02:49 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

PayPal Holdings, Inc. operates a technology platform that enables digital payments on behalf of merchants and consumers worldwide. It operates a two-sided network at scale that connects merchants and consumers that enables its customers to connect, transact, and send and receive payments through online and in person, as well as transfer and withdraw funds using various funding sources, such as bank accounts, PayPal or Venmo account balance, PayPal and Venmo branded credit products comprising its installment products, credit and debit cards, and cryptocurrencies, as well as other stored value products, including gift cards and eligible rewards. The company provides payment solutions under the PayPal, PayPal Credit, Braintree, Venmo, Xoom, Zettle, Hyperwallet, Honey, and Paidy names. The company was founded in 1998 and is headquartered in San Jose, California.

Regeneron Pharmaceuticals stock logo

Regeneron Pharmaceuticals NASDAQ:REGN

$566.32 +1.68 (+0.30%)
As of 02:49 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration with Mammoth Biosciences, Inc. to research, develop and commercialize in vivo CRISPR-based gene editing therapies for multiple tissues and cell types. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.

UBS Group stock logo

UBS Group NYSE:UBS

$38.38 +0.17 (+0.43%)
As of 02:49 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

UBS Group AG provides financial advice and solutions to private, institutional, and corporate clients worldwide. It operates through five divisions: Global Wealth Management, Personal & Corporate Banking, Asset Management, Investment Bank, and Non-core and Legacy. The company offers investment advice, estate and wealth planning, investing, corporate and banking, and investment management, as well as mortgage, securities-based, and structured lending solutions. It also provides personal banking products and services, such as deposits, credit and debit cards, and online and mobile banking, as well as lending, investments, retirement, and wealth management services; and corporate and institutional solutions, including equity and debt capital markets, syndicated and structured credit, private placements, leasing, traditional financing, and transaction banking solutions for payment and cash management services, trade and export finance, and global custody solutions. In addition, the company offers equities, fixed income, hedge funds, real estate and private markets, indexed and alternative beta strategies, asset allocation and currency investment strategies, customized multi-asset solutions, advisory and fiduciary services, and multi-manager hedge fund solutions and advisory services. Further, it advises clients on strategic business opportunities and helps them raise capital to fund their activities; enables its clients to buy, sell, and finance securities on capital markets and to manage their risks and liquidity; distributes, trades in, finances, and clears cash equities and equity-linked products; structures, originates, and distributes new equity and equity-linked issues; and originates, distributes, manages risk, and provides liquidity in foreign exchange, rates, credit and precious metals. The company was formerly known as UBS AG and changed its name to UBS Group AG in December 2014. UBS Group AG was founded in 1862 and is headquartered in Zurich, Switzerland.